Loading...
•
Dec 31, 2022
CVS Health Q4 2022 Earnings Report
CVS Health reported strong results driven by growth across all segments and outperformance across foundational businesses.
Key Takeaways
CVS Health's Q4 2022 results showed a total revenue increase of 9.5% to $83.8 billion and a GAAP diluted EPS of $1.75. The company's performance was driven by growth across all segments.
Total revenues increased to $83.8 billion, up 9.5% compared to prior year
GAAP diluted EPS of $1.75 and Adjusted EPS of $1.99
Operating income increased 62.3% primarily due to the absence of a store impairment charge and a pre-tax gain on the sale of bswift LLC.
Adjusted operating income decreased $141 million primarily driven by declines in the Retail/LTC and Corporate/Other segments, largely offset by increases in the Health Care Benefits and Pharmacy Services segments.
CVS Health
CVS Health
CVS Health Revenue by Segment
Revenue by Segment
Health Care Benefits Revenue
CapyFin.comHealth Services Revenue
CapyFin.comPharmacy & Consumer Wellness Revenue
CapyFin.com Forward Guidance
The Company issued its full-year 2023 GAAP diluted EPS guidance range of $7.73 to $7.93 and reaffirmed its full-year 2023 Adjusted EPS guidance range of $8.70 to $8.90. The Company also issued its full-year 2023 cash flow from operations guidance range of $12.5 billion to $13.5 billion.
Revenue & Expenses
Visualization of income flow from segment revenue to net income